Table 4.
Uni- and multi-variate analysis of the number of cycles and other baseline variables as potential predictors of overall survival.
Variable | Overall survival | |||||
---|---|---|---|---|---|---|
Univariate | Multivariate | |||||
HR | 95% CI | p-value | aHR | 95% CI | p-value | |
Number of cycles | ||||||
3 | Reference | – | Reference | Reference | – | Reference |
4 | 1.63 | 0.99, 2.69 | 0.061 | 1.66 | 0.99, 2.80 | 0.056 |
Clinical T stage | ||||||
<=2 | Reference | – | Reference | |||
>=3 | 0.85 | 0.52, 1.41 | 0.532 | – | – | – |
Sex | ||||||
Male | Reference | – | Reference | – | – | – |
Female | 1.57 | 0.90, 2.76 | 0.129 | – | – | – |
Age | 0.97 | 0.73, 1.28 | 0.811 | – | – | – |
Ecog | 0.97 | 0.85, 1.11 | 0.644 | – | – | – |
Charlson index | 1.00 | 0.98, 1.02 | 0.992 | – | – | – |
HB (g/dl) | 0.65 | 0.37, 1.14 | 0.083 | 1.00 | 0.98, 1.02 | 0.968 |
Creatinine (mg/dl) | 1.02 | 0.99, 1.04 | 0.250 | – | – | – |
PCR (mg/L) | 1.02 | 1.00, 1.03 | 0.013 | 1.01 | 0.99, 1.03 | 0.374 |
VES (mm/h) | 1.25 | 1.10, 1.42 | 0.001 | 1.01 | 1.00, 1.03 | 0.142 |
NLR | 1.03 | 1.01, 1.05 | 0.011 | 1.16 | 1.01, 1.34 | 0.040 |
Neutrophils x10^3/µL | 1.04 | 0.96, 1.12 | 0.397 | – | – | – |
Lymphocytes x10^3/µL | 1.06 | 0.90, 1.25 | 0.514 | – | – | – |
Monocytes x10^3/µL | 1.55 | 1.15, 2.07 | 0.030 | 1.12 | 0.96, 1.32 | 0.160 |
Eosinophils x10^3/µL | 0.78 | 0.01, 70.9 | 0.915 | – | – | – |
Basophils x10^3/µL | 1.00 | 1.00, 1.00 | 0.688 | – | – | – |
Platelets x10^3/µL | 0.63 | 0.39, 1.00 | 0.050 | 1.00 | 1.00, 1.00 | 0.641 |
Albumin (g/dl) | 0.91 | 0.85, 0.98 | 0.007 | 0.68 | 0.42, 1.12 | 0.131 |
BMI | 1.01 | 1.01, 1.02 | <0.001 | 0.95 | 0.88, 1.03 | 0.187 |
Total cholesterol level (mg/dl) | 1.01 | 0.99, 1.02 | 0.401 | – | – | – |
HDL (mg/dl) | 0.89 | 0.73, 1.10 | 0.276 | – | – | – |
Fibrinogen level (mg/dl) | 1.00 | 0.97, 1.04 | 0.973 | – | – | – |
Preoperative PCR (mg/L) | 1.00 | 0.97, 1.02 | 0.766 | – | – | – |
P-values and HR are computed with single and multiple Cox regression. Significant values are highlighted in bold.